Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
mRNA Expression in Lymphocytes of Glaucoma Patients
NCT00327509
Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma
NCT00494923
Correlation of Structure and Function in Glaucoma
NCT05954637
Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study
NCT02865473
Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma
NCT00917670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best corrected visual acuity 0.8 or better
* European
Exclusion Criteria
* Any neurological diseases
* Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
* Systemic drugs with potentially ocular involvement
* ocular drugs
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Erlangen-Nürnberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Erlangen-Nürnberg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anselm G Juenemann, Prof.
Role: STUDY_CHAIR
University Erlangen-Nuremberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital
Erlangen, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hohberger
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DFG-SFB539-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.